This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Recombinant immunotoxins development for HER2-based targeted cancer therapies
Cancer Cell International Open Access 06 September 2021
-
Selection of a novel DNA aptamer against OFA/iLRP for targeted delivery of doxorubicin to AML cells
Scientific Reports Open Access 14 May 2019
-
Role of Berberine in the Treatment of Methicillin-Resistant Staphylococcus aureus Infections
Scientific Reports Open Access 22 April 2016
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Youlden DR, Cramb SM, Dunn NA, Muller JM, Pyke CM, Baade PD . The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol 2012; 36: 237–248.
Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thurlimann B, Senn HJ et al. Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol 2011; 22: 1736–1747.
Cooke T, Reeves J, Lanigan A, Stanton P . HER2 as a prognostic and predictive marker for breast cancer. Ann Oncol 2001; 12: S23–S28.
Holbro T, Civenni G, Hynes NE . The ErbB receptors and their role in cancer progression. Exp Cell Res 2003; 284: 99–110.
Hoang MP, Sahin AA, Ordonez NG, Sneige N . HER-2/neu gene amplification compared with HER-2/neu protein overexpression and interobserver reproducibility in invasive breast carcinoma. Am J Clin Pathol 2000; 113: 852–859.
Lebeau A, Deimling D, Kaltz C, Sendelhofert A, Iff A, Luthardt B et al. Her-2/neu analysis in archival tissue samples of human breast cancer: comparison of immunohistochemistry and fluorescence in situ hybridization. J Clin Oncol 2001; 19: 354–363.
Tuerk C, Gold L . Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990; 249: 505–510.
Konry T, Hayman RB, Walt DR . Microspherebased rolling circle amplification microarray for the detection of DNA and proteins in a single assay. Anal Chem 2009; 81: 5777–5782.
Liu Z, Duan JH, Song YM, Ma J, Wang FD, Lu X et al. Novel HER2 aptamer selectively delivers cytotoxic drug to HER2-positive breast cancer cells in vitro. J Transl Med 2012; 10: 148.
Baner J, Nilsson M, Mendel-Hartvig M, Landegren U . Signal amplification of padlock probes by rolling circle replication. Nucleic Acids Res 1998; 26: 5073–5078.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chu, M., Kang, Jr., Wang, W. et al. Evaluation of human epidermal growth factor receptor 2 in breast cancer with a novel specific aptamer. Cell Mol Immunol 14, 398–400 (2017). https://doi.org/10.1038/cmi.2015.31
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/cmi.2015.31
This article is cited by
-
Recombinant immunotoxins development for HER2-based targeted cancer therapies
Cancer Cell International (2021)
-
Selection of a novel DNA aptamer against OFA/iLRP for targeted delivery of doxorubicin to AML cells
Scientific Reports (2019)
-
Role of Berberine in the Treatment of Methicillin-Resistant Staphylococcus aureus Infections
Scientific Reports (2016)